Diffusion Pharmaceuticals DFFN Income Statements

Conto economico

Quarter End	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	0	0	0	0	4,65M	2,49M	2,35M	3,29M
Reddito operativo	-2,92M	-4,25M	-4,27M	-2,29M	1,23M	-2,48M	-2,6M	-3M
Reddito ante imposte	-2,8M	-4,08M	-4,09M	-2,11M	6,4M	-2,36M	-2,51M	-2,32M
Reddito netto	-2,8M	-4,08M	-4,09M	-2,11M	6,4M	-2,36M	-2,51M	-2,32M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-2,92M	-4,25M	-4,27M	-2,29M	6,65M	-2,48M	-2,6M	-3M
EBITDA	-2,92M	-4,25M	-4,27M	-2,29M	1,23M	-2,48M	-2,6M	-3M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	0	0	0	0	0	0	0	7,15M
Reddito operativo	-18,37M	-11,35M	-18,96M	-11,55M	-15,98M	-24,68M	-15,97M	-7,81M
Reddito ante imposte	-18,4M	-2,42M	-18,81M	-11,47M	-15,86M	-24,54M	-15,59M	-2,17M
Reddito netto	-18,04M	-2,62M	-26,62M	-11,8M	-16,14M	-24,1M	-15,59M	-2,17M
Dividendi preferiti	0	-1,25M	-8,25M	0	-1,95M	0	0	0
Utile base per azione (EPS)	-1.739	-0.18	-7.831	-0.352	-0.252	-0.236	-7.587	-0.382
UTILE OPERATIVO	-18,37M	-11,35M	-18,96M	-11,55M	-15,98M	-24,68M	-15,97M	-2,39M
EBITDA	-18,35M	-11,28M	-11,92M	-11,45M	-15,87M	-15,94M	-15,97M	-7,81M